Wuhan Hiteck Biological Pharma Co.,Ltd. Posted 29.6 Million Yuan Net Loss in First Three Quarters of 2023

Wuhan Hiteck Biological Pharma Co.,Ltd. (武汉海特生物制药股份有限公司) (300683.SZ) reported a net loss of 29.6 million yuan in the first three quarters of 2023, reversing a net profit of 24.7 million yuan for the same period in the previous year.

Meanwhile, the company posted 438.4 million yuan in revenue, down 19.8% year-on-year.

At the end of the reporting period, it had 2.9 billion yuan in total assets and 332.7 million yuan in total liabilities, with a liability-to-asset ratio of 11.4%.